What's it going to take to get the bull market back on the path higher? Jim Cramer told his Mad Money viewers Tuesday that he can think of six things the market would like to see before its next leg higher.

The first thing on Cramer's list was Federal Reserve chairman Powell's statement tomorrow. Powell knows what the market needs to hear and should tell us the market is strong, but not too strong, and can easily absorb rate hikes while keeping inflation at bay.

Next, Cramer hopes to see the "cloud kings" continue to rally, after Oracle (ORCL) fell by 9.4% today. Others in the group rallied, which gave him hope for more strength to come.

Third, Cramer's hoping to hear something from the EU on taxes for Amazon (AMZN) . Anything less than 2% will spark shares of this online giant. Speaking of overseas, Cramer said the markets would love to see direct negotiations with China over trade.

Fifth, the markets would benefit from a continued rally in retail, with many names in this group already rallying, like Abercrombie & Fitch (ANF) , PVH (PVH) and Estee Lauder (EL) . And finally, we need to see some leadership -- and humility -- from Facebook (FB) , the Action Alerts PLUS holding that continues to be mired in controversy.

Add up all of these items and the markets would be ready to roar, Cramer concluded, we just need to see how many of them can come true over the next few days.

Over on Real Money, Cramer says retail stocks could really soar on a market snapback. Get more of Cramer's insights with a free trial subscription to Real Money. 

Off the Charts: Biotech Opportunities

In his "Off The Charts" segment, Cramer checked in with colleague Carolyn Boroden to comb the biotech sector and see if the charts uncovered any bargains.

Boroden noted that the iShares NASDAQ Biotech Index ETF (IBB) has been showing some signs of life. She noted the daily chart's symmetry, with similar $18 declines in late 2016 and again last month.

Boroden then looked at the daily chart of Regeneron (REGN) , which has fallen from $500 a share last summer to just $333 today. The decline is a key 127.2% decline for the stock, and the timing cycles seem to match, but so far, there's no tradable low.

A similar pattern was seen in Celgene (CELG) , which has declined from $147 to $82 a share. The signs point to a possible rally, but nothing actionable quite yet.

For a more in-depth technical look at biotech and to see the charts, read New Opportunities in Biotech.

Twitter's Sympathy Slip 

When a high-quality name drops 10% in a single day, that's the time to ask whether you have a broken stock or a broken company. In the case of Twitter (TWTR) , Cramer said today's 10.4% decline represents a buying opportunity.

Shares of Twitter had been falling in sympathy with Facebook yesterday, but today took a nosedive after reports that Israel was considering legal action against the company for allowing hate speech on its platform. Does a potential lawsuit deserve a 10% haircut for the stock? Cramer thought otherwise.

Cramer just spoke with Twitter's CFO, Anthony Noto, last week and was impressed with what he heard. Twitter's trolls are rapidly seeing their hateful speech getting buried, while the company is shutting down accounts that promote terrorism. Many fake followers have also been disappearing, along with the blue check marks of those who have proven to be less than deserving of them.

All of these efforts to clean up the platform cost money, Cramer admitted, but they are working. User growth is accelerating, as are revenues, in a remarkable turn from just a year ago.

Cramer said Twitter deserves credit for all these improvements, especially after four revenue beats in a row.

Facebook and the Sharks 

So what's next for Facebook? Cramer sat down with cybersecurity expert Robert Herjavec, founder and CEO of the privately held Herjavec Group and co-host of CNBC's Shark Tank, to find out.

Herjavec said there's some question as to whether what happened at Facebook constitutes a data breach or not, as the company is in the business of selling its users' information. The real problem, Herjavec explained, is that people don't take information security and privacy seriously, and they honestly don't even know what Facebook is doing with their information.

The U.K. is the leader in privacy and data protection, Herjavec said. They have a penalty for data loss that can be as high as 6% of sales. Here in the U.S., there are no such protections. While the Internet was designed to be free and open, Herjavec said, this unfortunately is one area where governments need to step in and regulate. There needs to be accountability.

Turning to the topic of bitcoin, Herjavec said the currency is incredibly speculative. But in the end, people love to make money and if Bitcoin is rocketing from $200 to $20,000, that's where people will place heir bets.

No-Huddle Offense

In his "No-Huddle Offense" segment, Cramer offered up some advice for how Facebook can get its reputation back. He said that clearly, what they're doing now isn't working, and it's time to get real.

Facebook is a $488 billion company with two executives that are household names. Those execs need to come out of hiding and take responsibility for what happened even if it wasn't their fault or intention. In the court of public opinion, you're already guilty until proven innocent.

Next, the company needs to be human and make some friends, something the company should theoretically be really good at. But hitting the talk show circuit and getting in front of the public, they can head off a lot of conspiracy theories and hype.

Take a page from the Jamie Dimon playbook, Cramer said. After suffering staggering trading losses at JPMorgan Chase (JPM) , Dimon publicly admitted that his company was not only "dumb," but also "stupid" for not seeing the losses coming.

Cramer and the AAP team are dealing head-on with the Facebook fiasco. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Lightning Round

In the Lightning Round, Cramer was bullish on Cara Therapeutics (CARA) , Take-Two Interactive (TTWO) and Constellation Brands (STZ) .

Cramer was bearish on Wells Fargo (WFC) , Cronos Group (CRON) , AK Steel Holding (AKS) and TrueCar (TRUE) .

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in FB, AMZN, STZ, JPM.

More from Jim Cramer

Jim Cramer on Bank of America, Tariffs and the Goldman Sachs CEO Change

Jim Cramer on Bank of America, Tariffs and the Goldman Sachs CEO Change

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Target, US Bancorp, BlackRock: 'Mad Money' Lightning Round

Target, US Bancorp, BlackRock: 'Mad Money' Lightning Round

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Jim Cramer on Google Cloud vs. IBM Cloud

Jim Cramer on Google Cloud vs. IBM Cloud